FinTrust Capital Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-700
Closed -$92K 1183
2021
Q1
$92K Sell
700
-300
-30% -$41.1K 0.03% 435
2020
Q4
$135K Buy
+1,000
New +$121K 0.04% 322
2019
Q4
Sell
-19
Closed -$2K 1080
2019
Q3
$2K Hold
19
﹤0.01% 984
2019
Q2
$2K Hold
19
﹤0.01% 945
2019
Q1
$2K Sell
19
-9
-32% -$766 ﹤0.01% 1087
2018
Q4
$2K Buy
+28
New +$1.92K ﹤0.01% 1091

Other funds holding EXAS

FinTrust Capital Advisors's EXAS Position: Q2 2021 in Review

FinTrust Capital Advisors sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 700 shares — an estimated $92K sold.

FinTrust Capital Advisors first reported a position in EXAS in Q4 2018 and held it in 6 quarters. The position peaked at $135K in Q4 2020. 622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • FinTrust Capital Advisors reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • FinTrust Capital Advisors sold 700 Exact Sciences shares in Q2 2021, an estimated $92K.
  • FinTrust Capital Advisors first reported a position in Exact Sciences in Q4 2018 and held it in 6 quarters.
  • FinTrust Capital Advisors's Exact Sciences position peaked at $135K in Q4 2020.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on FinTrust Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.